Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    May 2018
  1. DISANTO G, Zecca C, MacLachlan S, Sacco R, et al
    Prodromal symptoms of multiple sclerosis in primary care.
    Ann Neurol. 2018 May 8. doi: 10.1002/ana.25247.
    PubMed     Text format     Abstract available


    April 2018
  2. TANKOU SK, Regev K, Healy BC, Tjon E, et al
    A probiotic modulates the microbiome and immunity in multiple sclerosis.
    Ann Neurol. 2018 Apr 20. doi: 10.1002/ana.25244.
    PubMed     Text format     Abstract available


    March 2018
  3. CRAMER SP, Simonsen HJ, Varatharaj A, Galea I, et al
    Permeability of the blood-brain barrier predicts no evidence of disease activity at two years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis.
    Ann Neurol. 2018 Mar 31. doi: 10.1002/ana.25219.
    PubMed     Text format     Abstract available


  4. ANTEL J
    The reality of "ghosts" in authorship of clinical trials in multiple sclerosis.
    Ann Neurol. 2018 Mar 13. doi: 10.1002/ana.25199.
    PubMed     Text format    


  5. COLES A
    Authorship of phase 3 trials in multiple sclerosis.
    Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25203.
    PubMed     Text format    


  6. MAGLIOZZI R, Howell OW, Nicholas R, Cruciani C, et al
    Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.
    Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25197.
    PubMed     Text format     Abstract available


    January 2018
  7. ESHAGHI A, Prados F, Brownlee W, Altmann DR, et al
    Deep grey matter volume loss drives disability worsening in multiple sclerosis.
    Ann Neurol. 2018 Jan 13. doi: 10.1002/ana.25145.
    PubMed     Text format     Abstract available


    December 2017
  8. GREENFIELD AL, Hauser SL
    B Cell Therapy for Multiple Sclerosis: Entering an Era.
    Ann Neurol. 2017 Dec 15. doi: 10.1002/ana.25119.
    PubMed     Text format     Abstract available


    October 2017
  9. BARBOUR C, Kosa P, Komori M, Tanigawa M, et al
    Molecular-based diagnosis of Multiple Sclerosis and its progressive stage.
    Ann Neurol. 2017 Oct 23. doi: 10.1002/ana.25083.
    PubMed     Text format     Abstract available


  10. AZODI S, Nair G, Enose-Akahata Y, Charlip E, et al
    Imaging Spinal Cord Atrophy in Progressive Myelopathies: HTLV-I Associated Neurologic Disease (HAM/TSP) and Multiple Sclerosis (MS).
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25072.
    PubMed     Text format     Abstract available


  11. JENDE JME, Hauck GH, Diem R, Weiler M, et al
    Peripheral nerve involvement in multiple sclerosis Demonstration by magnetic resonance neurography.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25068.
    PubMed     Text format     Abstract available


  12. MAINERO C, Louapre C
    Unravelling cortical pathology in multiple sclerosis using the T1-/T2-weighted ratio?
    Ann Neurol. 2017 Oct 4. doi: 10.1002/ana.25063.
    PubMed     Text format    


  13. WIJNANDS JMA, Tremlett H
    Concussion may not cause multiple sclerosis.
    Ann Neurol. 2017 Oct 4. doi: 10.1002/ana.25061.
    PubMed     Text format    


  14. MONTGOMERY S, Hiyoshi A, Burkill S, Alfredsson L, et al
    Reply to: Concussion may not cause multiple sclerosis.
    Ann Neurol. 2017 Oct 4. doi: 10.1002/ana.25062.
    PubMed     Text format    


    September 2017
  15. FITZGERALD KC, Munger KL, Ascherio A
    Reply to "Stratified analyses are necessary to verify the influence of salt intake in multiple sclerosis".
    Ann Neurol. 2017 Sep 29. doi: 10.1002/ana.25055.
    PubMed     Text format    


  16. MONTGOMERY S, Hiyoshi A, Burkill S, Alfredsson L, et al
    Concussion in adolescence and risk of multiple sclerosis.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25036.
    PubMed     Text format     Abstract available


    August 2017
  17. NAKAMURA K, Chen JT, Ontaneda D, Fox RJ, et al
    T1-/T2-weighted ratio differs in demyelinated cortex of multiple sclerosis.
    Ann Neurol. 2017 Aug 18. doi: 10.1002/ana.25019.
    PubMed     Text format     Abstract available


  18. RIGHART R, Biberacher V, Jonkman LE, Klaver R, et al
    Cortical pathology in MS detected by the T1/T2-weighted ratio from routine MRI.
    Ann Neurol. 2017 Aug 18. doi: 10.1002/ana.25020.
    PubMed     Text format     Abstract available


    July 2017
  19. YATES RL, Esiri MM, Palace J, Jacobs B, et al
    Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.
    Ann Neurol. 2017 Jul 18. doi: 10.1002/ana.24997.
    PubMed     Text format     Abstract available


  20. FISSOLO N, Pignolet B, Matute-Blanch C, Trivino JC, et al
    MMP9 is decreased in natalizumab-treated MS patients at risk for PML.
    Ann Neurol. 2017 Jul 6. doi: 10.1002/ana.24987.
    PubMed     Text format     Abstract available


    May 2017
  21. FITZGERALD KC, Munger KL, Hartung HP, Freedman MS, et al
    Sodium intake and multiple sclerosis activity and progression in BENEFIT.
    Ann Neurol. 2017 May 26. doi: 10.1002/ana.24965.
    PubMed     Text format     Abstract available


  22. DISANTO G, Barro C, Benkert P, Naegelin Y, et al
    Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
    Ann Neurol. 2017 May 16. doi: 10.1002/ana.24954.
    PubMed     Text format     Abstract available


  23. CUI QL, Khan D, Rone M, Rao V, et al
    Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?
    Ann Neurol. 2017 May 3. doi: 10.1002/ana.24944.
    PubMed     Text format     Abstract available


  24. IAFFALDANO P, Simone M, Lucisano G, Ghezzi A, et al
    Prognostic indicators in pediatric clinically isolated syndrome.
    Ann Neurol. 2017;81:729-739.
    PubMed     Text format     Abstract available


    April 2017
  25. ANDRODIAS G, Bernard E, Biotti D, Collongues N, et al
    Multiple sclerosis broke my heart.
    Ann Neurol. 2017 Apr 24. doi: 10.1002/ana.24935.
    PubMed     Text format     Abstract available


  26. SELMAJ I, Cichalewska M, Namiecinska M, Galazka G, et al
    Global Exosome Transcriptome Profiling Reveals Biomarkers for Multiple Sclerosis.
    Ann Neurol. 2017 Apr 15. doi: 10.1002/ana.24931.
    PubMed     Text format     Abstract available


    December 2016
  27. HERRANZ E, Hooker JM, Izquierdo-Garcia D, Loggia ML, et al
    11 C-PBR28 increase in multiple sclerosis reflects neuroinflammation.
    Ann Neurol. 2016 Dec 29. doi: 10.1002/ana.24865.
    PubMed     Text format    


  28. RAFFEL J, Sridharan S, Nicholas R
    [11 C]PBR-28 PET in multiple sclerosis: Neuroinflammation or otherwise?
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24853.
    PubMed     Text format    


    October 2016
  29. GOBEL K, Kraft P, Pankratz S, Gross CC, et al
    Prothrombin and factor X are elevated in multiple sclerosis patients.
    Ann Neurol. 2016 Oct 24. doi: 10.1002/ana.24807.
    PubMed     Text format     Abstract available


    September 2016
  30. HERRANZ E, Gianni C, Louapre C, Treaba CA, et al
    The neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Ann Neurol. 2016 Sep 30. doi: 10.1002/ana.24791.
    PubMed     Text format     Abstract available


    August 2016
  31. CORTESE M, Riise T, Bjornevik K, Bhan A, et al
    Pre-clinical disease activity in multiple sclerosis- a prospective study on cognitive performance prior to first symptom.
    Ann Neurol. 2016 Aug 23. doi: 10.1002/ana.24769.
    PubMed     Text format     Abstract available


    July 2016
  32. CREE B, Gourraud PA, Oksenberg JR, Bevan C, et al
    Long-term evolution of multiple sclerosis disability in the treatment era.
    Ann Neurol. 2016 Jul 27. doi: 10.1002/ana.24747.
    PubMed     Text format     Abstract available


  33. WINDER K, Linker RA, Seifert F, Deutsch M, et al
    Neuroanatomic Correlates of Female Sexual Dysfunction in Multiple Sclerosis.
    Ann Neurol. 2016 Jul 27. doi: 10.1002/ana.24746.
    PubMed     Text format     Abstract available


    June 2016
  34. GERDES LA, Held K, Beltran E, Berking C, et al
    CTLA-4 as immunological checkpoint in the development of multiple sclerosis.
    Ann Neurol. 2016 Jun 28. doi: 10.1002/ana.24715.
    PubMed     Text format     Abstract available


    May 2016
  35. JOKUBAITIS VG, Spelman T, Kalincik T, Lorscheider J, et al
    Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
    Ann Neurol. 2016 May 4. doi: 10.1002/ana.24682.
    PubMed     Text format     Abstract available


    April 2016
  36. BODINI B, Veronese M, Turkheimer F, Stankoff B, et al
    Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
    Ann Neurol. 2016 Apr 21. doi: 10.1002/ana.24667.
    PubMed     Text format    


  37. MATIAS-GUIU JA, Cabrera-Martin MN, Oreja-Guevara C, Carreras JL, et al
    PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
    Ann Neurol. 2016 Apr 21. doi: 10.1002/ana.24666.
    PubMed     Text format    


  38. HOKARI M, Yokoseki A, Arakawa M, Saji E, et al
    Clinicopathological features in anterior visual pathway in neuromyelitis optica.
    Ann Neurol. 2016;79:605-24.
    PubMed     Text format     Abstract available


    March 2016
  39. ALPING P, Frisell T, Novakova L, Islam-Jakobsson P, et al
    Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
    Ann Neurol. 2016 Mar 31. doi: 10.1002/ana.24651.
    PubMed     Text format     Abstract available


  40. LASSMANN H
    Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
    Ann Neurol. 2016 Mar 9. doi: 10.1002/ana.24632.
    PubMed     Text format    


  41. JELCIC I, Jelcic I, Kempf C, Largey F, et al
    Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
    Ann Neurol. 2016;79:404-18.
    PubMed     Text format     Abstract available


    February 2016
  42. BODINI B, Veronese M, Garcia-Lorenzo D, Battaglini M, et al
    Dynamic imaging of individual remyelination profiles in multiple sclerosis.
    Ann Neurol. 2016 Feb 18. doi: 10.1002/ana.24620.
    PubMed     Text format     Abstract available


    January 2016
  43. DESAI RA, Davies AL, Tachrount M, Kasti M, et al
    Cause and prevention of demyelination in a model multiple sclerosis lesion.
    Ann Neurol. 2016 Jan 27. doi: 10.1002/ana.24607.
    PubMed     Text format     Abstract available


    November 2015
  44. KANTARCI OH, Lebrun C, Siva A, Keegan MB, et al
    Primary Progressive MS evolving from Radiologically Isolated Syndrome.
    Ann Neurol. 2015 Nov 24. doi: 10.1002/ana.24564.
    PubMed     Text format     Abstract available


  45. XIA Z, White CC, Owen EK, Von Korff A, et al
    GEMS Project: A Platform to Investigate Multiple Sclerosis Risk.
    Ann Neurol. 2015 Nov 19. doi: 10.1002/ana.24560.
    PubMed     Text format     Abstract available


  46. SAIDHA S, Al-Louzi O, Ratchford JN, Bhargava P, et al
    Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study.
    Ann Neurol. 2015;78:801-13.
    PubMed     Text format     Abstract available


    October 2015
  47. CASTILLO-GOMEZ E, Kastner A, Steiner J, Schneider A, et al
    The brain as 'immunoprecipitator' of serum autoantibodies against NMDAR1.
    Ann Neurol. 2015 Oct 27. doi: 10.1002/ana.24545.
    PubMed     Text format     Abstract available


    August 2015
  48. SATO S, Yamamoto K, Matsushita T, Isobe N, et al
    Copy number variations in multiple sclerosis and neuromyelitis optica.
    Ann Neurol. 2015 Aug 21. doi: 10.1002/ana.24511.
    PubMed     Text format     Abstract available


  49. FREEMAN L, Garcia-Lorenzo D, Bottin L, Leroy C, et al
    The neuronal component of gray matter damage in multiple sclerosis: A [ C]flumazenil positron emission tomography study.
    Ann Neurol. 2015 Aug 21. doi: 10.1002/ana.24468.
    PubMed     Text format     Abstract available


  50. FRISCHER JM, Weigand SD, Guo Y, Kale N, et al
    Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
    Ann Neurol. 2015 Aug 3. doi: 10.1002/ana.24497.
    PubMed     Text format     Abstract available


    July 2015
  51. LAROCHELLE C, Lecuyer MA, Alvarez JI, Charabati M, et al
    Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation.
    Ann Neurol. 2015;78:39-53.
    PubMed     Text format     Abstract available


    June 2015
  52. JEHNA M, Pirpamer L, Khalil M, Fuchs S, et al
    Periventricular lesions correlate with cortical thinning in multiple sclerosis.
    Ann Neurol. 2015 Jun 18. doi: 10.1002/ana.24461.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: